Breast Cancer Subtypes Linked To Survival From Secondary Brain Tumors

[Hopeful]

ER+/Her2- and Triple negatives (ER-/PR-/Her2-) fared the worst, Triple Positives (ER+/PR+/Her2+) and Her2+/ER- treated with Herceptin fared the best:

http://www.medicalnewstoday.com/articles/98852.php

Provisional pdf:

http://breast-cancer-research.com/content/pdf/bcr1870.pdf

Hopeful